Research Study
Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis
![Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/food-beverage-nutrition/nutraingredients-usa.com/product-innovations/pycnogenol-r-reduces-risk-of-post-thrombotic-syndrome-and-recurrent-thrombosis/8782274-1-eng-GB/Pycnogenol-R-Reduces-Risk-of-Post-Thrombotic-Syndrome-and-Recurrent-Thrombosis.png)
New research shows daily supplementation with Pycnogenol®, French maritime pine bark extract may reduce the incidence of post-thrombotic syndrome (PTS) and recurrent thrombosis, a potentially life-threatening condition that may occur as a long-term complication of deep vein thrombosis (DVT).
The expansive study tested 815 individuals at-risk of post-thrombosis or recurrent thrombosis for six years following a thrombotic event and reports showed Pycnogenol® performed better than aspirin, ticlopidine and sulodexide in the treatment of DVT and PTS symptoms.
This study builds upon previous research on Pycnogenol®'s benefits for its vein and circulation health benefits.
Visit booth #3873 at SupplySide West to discuss the potential of Pycnogenol® as an active ingredient in travel health formulations.